Erratum

In the article by Markantes et al. entitled “Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism” [Eur Thyroid J, DOI: 10.1159/000508216], the Disclosure Statement did not mention the conflicts of interest of Mrs. Ioulia Tseti. It should read as follows:

Disclosure Statement

Mrs. Ioulia Tseti is the CEO of Uni-Pharma S.A., Athens, Greece. All other authors do not have any conflicts of interest to declare.